2025
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease
Taylor R, Heerspink H, Buyse M, Ciani O, Detournay B, Gallego D, Mauro J, Sinha S, Trapero-Bertran M, Inker L. Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease. EClinicalMedicine 2025, 88: 103465. PMID: 40932851, PMCID: PMC12418889, DOI: 10.1016/j.eclinm.2025.103465.Peer-Reviewed Original ResearchGlomerular filtration rateHealth technology assessmentSurrogate endpointsTarget outcomesManagement of chronic kidney diseaseDuration of clinical trialsChronic kidney diseaseReimbursement of treatmentTechnology assessmentHealthcare policy makingKidney transplantationFiltration rateClinical trialsInnovative therapiesKidney diseasePatient accessPatientsTreatment effectsEndpointReimbursement decisionsRobust evidenceTreatmentOutcomesHealthReimbursementSelecting Cost-Effectiveness Methods for Health Benefits Package Design: A Systematic Approach
Nemzoff C, Sweeney S, Baltussen R, Vassall A. Selecting Cost-Effectiveness Methods for Health Benefits Package Design: A Systematic Approach. International Journal Of Health Policy And Management 2025, 14: 1-9. PMID: 40767209, PMCID: PMC12089834, DOI: 10.34172/ijhpm.8562.Peer-Reviewed Original ResearchHealth benefits packageCost-effectiveness analysisHealth technology assessmentHealth benefit package designBenefit package designFollow-up surveyCost-effectiveCost-effectiveness analysis methodsCost-effectiveness modelHealth economicsLiterature reviewGlobal evidenceBenefit packageHealthPublic healthTechnology assessmentAssessment methodsSurvey of authorsExpert opinionMethod selectionPrioritization criteriaExtensive investmentLocal designAssess CEAssessment
2024
HTA224 A Roadmap to the Use of Value of Information Analysis in Health Technology Assessment: An International Study of Barriers, Facilitators, and Potential Applications
Grimm S, Glynn D, Coyle D, Jalal H, Koffijberg E, Tuffaha H, Vervaart M, Welton N, Wilson E, Rothery C, Kunst N. HTA224 A Roadmap to the Use of Value of Information Analysis in Health Technology Assessment: An International Study of Barriers, Facilitators, and Potential Applications. Value In Health 2024, 27: s398. DOI: 10.1016/j.jval.2024.10.2049.Peer-Reviewed Original ResearchOP09 Investigating The Nature And Scope Of Innovative Payment And Pricing Schemes For Health Technologies
Ardito V, Cavallaro L, Drummond M, Ciani O. OP09 Investigating The Nature And Scope Of Innovative Payment And Pricing Schemes For Health Technologies. International Journal Of Technology Assessment In Health Care 2024, 40: s5-s5. PMCID: PMC11719172, DOI: 10.1017/s0266462324000734.Peer-Reviewed Original ResearchHealth technology assessmentHealth technologiesWeb of ScienceNested evaluationInnovation paymentsSystematic reviewStudy protocolTechnology assessmentHealthImplementation challengesData collection needsAgency websitesExpenditure capsAffordability issuesPayment schemeProduct categoriesPricing schemeDistribution of riskCollection needsPricePROSPEROReimbursementAssessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force
Fleurence R, Kent S, Adamson B, Tcheng J, Balicer R, Ross J, Haynes K, Muller P, Campbell J, Bouée-Benhamiche E, García Martí S, Ramsey S. Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force. Value In Health 2024, 27: 692-701. PMID: 38871437, PMCID: PMC11182651, DOI: 10.1016/j.jval.2024.01.019.Peer-Reviewed Original ResearchConceptsElectronic health recordsHealth technology assessmentElectronic health record dataEHR-derived dataHealth record dataTechnology assessmentHealth technology assessment agenciesHealth recordsGenerative artificial intelligenceData provenanceLanguage modelEvidence gapsPractice reportArtificial intelligenceRecord dataISPOR Task ForceData characteristicsData governanceReal worldEvidence developmentTask ForceReal World DataISPORChecklistRelevant items
2023
Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum
Gladwell D, Ciani O, Parnaby A, Palmer S. Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum. PharmacoEconomics 2023, 42: 137-144. PMID: 37991631, DOI: 10.1007/s40273-023-01334-y.Peer-Reviewed Original ResearchAdvanced therapy medicinal productsTherapy medicinal productsSurrogate primary endpointTrial-level correlationSingle-arm studyMedicinal productsMechanism of actionHealth technology assessmentPrimary endpointPatient relevanceNovel interventionsAdvanced therapiesTreatment effectsEndpointTechnology assessmentSurrogacy relationshipsSurrogate relationshipsMedical technologyTherapyAdditional avenues
1995
Evaluating health services: the importance of patients' preferences and quality of life.
Yin D, Forman H, Langlotz C. Evaluating health services: the importance of patients' preferences and quality of life. American Journal Of Roentgenology 1995, 165: 1323-8. PMID: 7484556, DOI: 10.2214/ajr.165.6.7484556.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsQuality of lifeHealth statesCost-effectiveness of medical proceduresHealth-related quality of lifePatient preferencesHealth-related qualityHealth care programsQuality-adjusted life years methodMeasure patient preferencesHealth care dollarsMedical proceduresHealth programsHealth servicesCare programCost-effectiveness analysisHealth insuranceLife yearsOutcomes researchPatient outcomesHealthTechnology assessmentClinical researchMonetary valueDollar amountMulticenter Trial to Evaluate Vascular Magnetic Resonance Angiography of the Lower Extremity
Baum R, Rutter C, Sunshine J, Blebea J, John, Carpenter J, Dickey K, Quinn S, Gomes A, Grist T, McNeil B, Axel L, Holland G, Cope C, Haskal Z, Shlansky-Goldberg R, Soulen M, Vu D, Alspaugh J, Fowl R, Kempczinski R, McCauley T, Egglin T, Pollak J, Rosenblatt M, Burdge C, Gusberg R, Meier G, Sumpio B, Demlow T, Peterson B, Swan J, Sproat I, Hoch J, Acher C, Yoon H, Quinones-Baldrich W, Moore W, Ahn S, Caldwell T. Multicenter Trial to Evaluate Vascular Magnetic Resonance Angiography of the Lower Extremity. JAMA 1995, 274: 875-880. DOI: 10.1001/jama.1995.03530110037032.Peer-Reviewed Original ResearchMagnetic resonance angiographyContrast arteriographyPatent segmentsResonance angiographyTreatment planNormal segmentsPeripheral vascular diseaseAtherosclerotic occlusive diseaseRest painOcclusive diseaseConsecutive patientsMulticenter trialProspective studySurgical interventionPresurgical evaluationVascular diseaseCommunity hospitalContrast angiographyTechnology assessmentLogistic analysisLower ExtremityTissue lossUS hospitalsPlanning treatmentArterial segments
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply